EBNA3C is encoded by Epstein-Barr virus (EBV), which is one of the latent proteins. As a potent transcriptional coregulator that interacts with numerous cellular proteins, EBNA3C is essentially involved in regulating multiple important cellular pathways, including cell cycle and apoptosism. Therefore, EBNA3C is playing a critical role in EBV-induced growth transformation of primary B lymphocytes. EBNA3C is related to Burkitt's lymphoma (BL), nasopharyngeal carcinoma (NPC), and AIDS-associated lymphomas.
|CAT||Product Name||Target Species||Antibody Clone||Antibody Host||Receptor Construction||Vector Type||Targeting Cell Type||Inquiry & Datasheet|
|CAR-MZ043||Anti-EBNA3C (EBNA Clone 315) h(41BB-CD3ζ) CAR, pCDCAR1||Virus||EBNA Clone 315||Human||scFv-41BB-CD3ζ||Retroviral||NK cell|
|CAT||Product Name||Clone||Promotor||Packaging System||Targeting Diseases||Inquiry & Datasheet|
|VP-CAR-LC764||Lenti-EBNA3C CAR (scFv-41BB-CD3ζ, EBNA Clone 315) Viral Particle||EBNA Clone 315||EF1a||Lentivirus|
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE